Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125480261 | 12548026 | 1 | I | 20160418 | 20160628 | 20160712 | 20160712 | EXP | US-AJANTA PHARMA USA INC.-1054913 | AJANTA PHARMA | SHAAYA EA, GROCOTT OR, LAING O, THIBERT RL. SEIZURE TREATMENT IN ANGELMAN SYNDROME: A CASE SERIES FROM THE ANGELMAN?SYNDROME CLINIC AT MASSACHUSETTS GENERAL HOSPITAL. EPILEPSY AND BEHAVIOR. 2016; 60:138-141 | 0.00 | Y | 0.00000 | 20160712 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125480261 | 12548026 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | U | 201293 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125480261 | 12548026 | 1 | Seizure |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125480261 | 12548026 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125480261 | 12548026 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |